Our Opinion

Immunome Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Modulation of IL-38 levels in mouse models correlates with immune responsiveness, tumor growth” (Page 15) Read the full document

Company Description

Immunome, Inc. is a biopharmaceutical company utilizing its human memory B cell platform to discover and develop antibody therapeutics. The Company’s primary focus areas are oncology and infectious diseases.

Company Website: https://www.immunome.com